Aytu Biopharma, Inc.
AYTU
$2.13
-$0.05-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.58M | 1.97M | -19.82M | 3.99M | 788.00K |
| Total Depreciation and Amortization | 885.00K | 803.00K | 1.29M | 1.32M | 1.29M |
| Total Amortization of Deferred Charges | 29.00K | 29.00K | 26.00K | 27.00K | 28.00K |
| Total Other Non-Cash Items | 9.36M | -3.39M | 19.60M | -1.63M | -2.46M |
| Change in Net Operating Assets | 3.98M | -23.00K | 1.70M | -10.16M | 3.26M |
| Cash from Operations | 3.68M | -618.00K | 2.80M | -6.46M | 2.91M |
| Capital Expenditure | -17.00K | -- | -17.00K | -69.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 151.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -3.00M | -- | -- |
| Cash from Investing | -17.00K | -- | -3.02M | -69.00K | 145.00K |
| Total Debt Issued | -5.80M | 5.81M | 892.00K | 6.02M | -258.00K |
| Total Debt Repaid | -465.00K | -464.00K | -464.00K | -464.00K | -465.00K |
| Issuance of Common Stock | -- | -- | 14.84M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -3.05M | -2.28M | -1.25M | -2.04M |
| Cash from Financing | -6.26M | 2.30M | 12.99M | 4.30M | -2.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.61M | 1.68M | 12.78M | -2.23M | 290.00K |